使用西门子高灵敏度心脏托洛因I测定器加速诊断心肌梗塞的途径
Hiroyuki Azuma1, Masafumi Tada2, Hideyuki Matano3
1Department of Emergency Medicine, Fukui Prefectural Hospital, Fukui, Japan.
Clinical biochemistry
|February 16, 2025
概括
高-STEACS途径在早期呈现者中有效地诊断出心肌梗塞 (MI),使用高灵敏度心脏素I (hs-cTnI) 测试. 这种途径排除了许多患者,没有错过任何心脏病发病例,确保了安全性和效率.
科学领域:
- 心脏病学 心脏病学
- 紧急医疗 紧急医疗
- 生物标志物检测试验 生物标志物检测
背景情况:
- 在早期呈现者中,对心肌梗塞 (MI) 的高灵敏性心脏托罗素I (hs-cTnI) 诊断途径的研究有限.
- 西门子ADVIA Centaur hs-cTnI测定被广泛使用,需要对其相关的诊断策略进行评估.
研究的目的:
- 综合评估基于hs-cTnI的各种hs-cTnI诊断途径的效率和安全性,用于在急诊室患者中怀疑心脏病发作.
- 为了比较仅使用hs-cTnI的途径与包含临床数据的途径.
主要方法:
- 一项前性多中心队列研究,涉及414名患者,在症状出现后6小时内到急诊室.
- 评估了三个只有hs-cTnI的途径 (High-STEACS,ESC 0/1-h,0/2-h) 和四个包括临床数据的途径 (ADAPT,EDACS,HEART,GRACE).
- 评估负预测值 (NPV),灵敏度和排除1型心脏病发作或30天内心脏病死亡的主要结果的患者百分比.
主要成果:
- 高-STEACS途径排除了62.0%没有错过心脏病发作病例的患者,显示出更高的效率.
- 虽然ESC 0/1-h和 0/2-h路径具有较高的NPV和灵敏度,但排除了较少的患者 (35.9%-45.2%).
- 临床途径 (ADAPT,EDACS,HEART) 显示出良好的安全性,但效率较低 (15-27%被排除);GRACE途径错过了两个结果.
结论:
- 高STEACS路径是早期MI呈现者最有效的基于hs-cTnI的策略.
- 这条通路保持了出色的安全性能,使其成为紧急心脏病学的宝贵工具.
- 在没有心脏病发作的老年患者中,考虑hs-cTnI水平至关重要,因为许多患者的基线度升高.
更多相关视频
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
24.2K
09:23Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum
Published on: December 13, 2017
6.2K
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
82
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
82
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
41
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
41